RecallDepth
Class II Ongoing

medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India

This recall is currently active, issued January 15, 2025. It was issued by Eugia Us Llc.

Company
Eugia Us Llc
Recall Initiated
December 18, 2024
Posted
January 15, 2025
Recall Number
D-0185-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
19872 vials
Firm Location
East Windsor, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations

Distribution

Nationwide in the US

Lot / Code Info

Lot No.: 1MP24069, Exp.: 08/2026

More recalls by Eugia Us Llc

View all recalls by this company →

Other recent Class II Drug recalls